| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 02/28/2002 | US20020026051 Calcium channel antagonists with cardiovascular, antiasthmatic and antibronchoconstriction activity |
| 02/28/2002 | US20020026050 Thrombin receptor antagonists |
| 02/28/2002 | US20020026047 For use in Hydrogen Bonding Liquid Chromatography, environmental remediation by removal of undesired ions or neutral molecules, removal of phosphate for kidney dialysis, drug delivery, separation |
| 02/28/2002 | US20020026038 Slurrying a solid comprising clarithromycin Form 0 in water; macrolide antibiotic related to erythromycin A |
| 02/28/2002 | US20020026034 3-aminoethyl-n-amidino-2,5-dihydropyrrole derivatives having arginine mimetic properties |
| 02/28/2002 | US20020025985 Apoptosis inhibitor |
| 02/28/2002 | US20020025984 Tablets, capsules |
| 02/28/2002 | US20020025983 Anticoagulant mixture; cardiovascular disordrs; premenstrual disorders; bone disorders |
| 02/28/2002 | US20020025982 Method for the preparation of citalopram |
| 02/28/2002 | US20020025981 Synergistic mixture of amlodipine and statins |
| 02/28/2002 | US20020025980 Single morphic forms of metalloproteinase inhibitors |
| 02/28/2002 | US20020025979 Therapeutic inhibitor of vascular smooth muscle cells |
| 02/28/2002 | US20020025978 Veterinary medicine |
| 02/28/2002 | US20020025976 Thiazole compounds and pharmaceutical compositions for inhibiting protein kinases and methods for their use |
| 02/28/2002 | US20020025972 Comprehensive pharmacologic therapy for treatment of obesity |
| 02/28/2002 | US20020025971 Synergistic mixture |
| 02/28/2002 | US20020025970 Materials and methods for the treatment of gastroesophageal reflux disease |
| 02/28/2002 | US20020025969 Genign prostatic hyperolasia |
| 02/28/2002 | US20020025968 Use as anticancer agents; e.g. 4 -(2-(2-hydroxyethoxy)ethyl)amino-6-acetyl-2-(1-imidazolyl)quinazoline; regulating apoptosis |
| 02/28/2002 | US20020025967 Antiserotinone agents |
| 02/28/2002 | US20020025966 Pyrrolo[3,4-d]pyrimidinone derivatives and their use as medicaments |
| 02/28/2002 | US20020025965 Antiserotonine agents |
| 02/28/2002 | US20020025964 In cellulose binder; bioavailability, storage stability |
| 02/28/2002 | US20020025962 Compounds of the saframycin-ecteinascidin series, uses, and synthesis thereof |
| 02/28/2002 | US20020025961 Platelet ADP receptor inhibitors |
| 02/28/2002 | US20020025960 Heterocycle carboxamides as antiviral agents |
| 02/28/2002 | US20020025959 Heterocycle carboxamides as antiviral agents |
| 02/28/2002 | US20020025957 Anticoagulants, cardiovascular disorders |
| 02/28/2002 | US20020025956 Nervous system, psychological disorders |
| 02/28/2002 | US20020025955 Substituted lactams as inhibitors of A beta protein production |
| 02/28/2002 | US20020025954 Beta-lactamase inhitiors |
| 02/28/2002 | US20020025953 Using oil |
| 02/28/2002 | US20020025952 Combinations of statins, estrogens and estrogenic agents |
| 02/28/2002 | US20020025951 Urogenital disorders |
| 02/28/2002 | US20020025950 Anticarcinogenic agents |
| 02/28/2002 | US20020025949 Anti-epileptogenic agents |
| 02/28/2002 | US20020025946 Acylated cyclodextrin: guest molecule inclusion complexes |
| 02/28/2002 | US20020025945 Deacetylation chitin with base |
| 02/28/2002 | US20020025944 Use of clioquinol for the therapy of Alzheimer's disease |
| 02/28/2002 | US20020025943 Nucleoside analog compositions and uses thereof |
| 02/28/2002 | US20020025941 Combination product intended for carrying out a cytotoxic treatment, in particular an antitumour treatment, in a mammal |
| 02/28/2002 | US20020025940 Insertion virus into reporter gene |
| 02/28/2002 | US20020025939 Chorionic gonadortropin dna vaccines and methods |
| 02/28/2002 | US20020025938 Bactericides |
| 02/28/2002 | US20020025936 Motilide compounds |
| 02/28/2002 | US20020025935 Antiinflammatory agents; autoimmune diseases; central nervous system disorders |
| 02/28/2002 | US20020025934 Renin inhibitor |
| 02/28/2002 | US20020025929 Concurrent aministering parathyroid hormone and benzothiophene compound |
| 02/28/2002 | US20020025926 Enantiomers of S-adenosyl-l-methionine |
| 02/28/2002 | US20020025916 Naphthalimide compositions and uses thereof |
| 02/28/2002 | US20020025911 Active carbon; removal toxic compounds by adsorption |
| 02/28/2002 | US20020025578 Intensified expression of nucleotide sequences in mammal; administer nucleic acids to mammal, transfect nucleotide sequence using voltage, monitor mammal for gene expression |
| 02/28/2002 | US20020025562 Plasma-like solution |
| 02/28/2002 | US20020025556 Stable factor VIII / vWF-complex |
| 02/28/2002 | US20020025543 Methods and kits for diagnosing tumorigenicity and determining resistance to the antineoplastic effects of antiestrogen therapy |
| 02/28/2002 | US20020025516 Nrde |
| 02/28/2002 | US20020025350 Dietary supplements |
| 02/28/2002 | US20020025347 Administering a metabolite of a Salviae Miltiorrhizae Radix herb to the diabetic individual for therapy of diabetic nephropathy |
| 02/28/2002 | US20020025346 Administering a dose of elemental calcium that is effective to reduce carcinogenesis |
| 02/28/2002 | US20020025344 As antimicrobial agent |
| 02/28/2002 | US20020025343 For infusing into human patients |
| 02/28/2002 | US20020025342 Novel administration form comprising an acid-labile active compound |
| 02/28/2002 | US20020025341 Controlled release formulation of divalproex sodium |
| 02/28/2002 | US20020025339 Antidepressant, sustained release, for controlling blood plasma level of durg venlafaxine hydrochloride |
| 02/28/2002 | US20020025338 Bioavailable dosage form of isotrentinoin |
| 02/28/2002 | US20020025331 Cosmetic compositions containing substituted amine derivatives |
| 02/28/2002 | US20020025327 Use of neurotoxin therapy for treatment of urologic and related disorders |
| 02/28/2002 | US20020025326 Delivery vehicle composition and methods for delivering antigens and other drugs |
| 02/28/2002 | US20020025321 Composition for the prevention and/or treatment of atherosclerosis |
| 02/28/2002 | US20020025310 Dietary supplements |
| 02/28/2002 | US20020025307 Gene therapy, testing |
| 02/28/2002 | US20020025305 Cell-cycle regulatory proteins, and uses related thereto |
| 02/28/2002 | US20020025303 Cosmetic and/or dermatological composition containing a derivative of methylated silanol and a derivative of hydrolysed plant protein |
| 02/28/2002 | US20020025301 Novel flavonoids and their use in cosmetic and dermatological preparations |
| 02/28/2002 | US20020025300 Edible herbal compositions for relieving nicotine craving |
| 02/28/2002 | US20020025299 Stable pharmaceutical solution formulations for pressurised metered dose inhalers |
| 02/28/2002 | US20020023877 Methods for the production of D-chiro-inositol and the use of D-chiro-inositol obtained therefrom |
| 02/28/2002 | DE10111815A1 Treatment of epilepsy, especially drug-resistant epilepsy, using agents reducing inhibition of potassium-coupled outward transport of chloride from nerve cells, e.g. propranolol |
| 02/28/2002 | DE10040525A1 New 6-acylamino-4-amino-quinazoline or quinoline derivatives, are tyrosine kinase-mediated signal transduction inhibitors useful e.g. for treating tumors or respiratory or gastrointestinal diseases |
| 02/28/2002 | DE10040174A1 Treatment of coccidiosis comprises administration of haloalkylsulfonyl substituted phenoxyphenyl-triazinetrione derivatives |
| 02/28/2002 | DE10040110A1 Verwendung von Triazintrion-Sulfoxiden zur Bekämpfung von Coccidiosen Use of triazinetrione sulfoxides to combat coccidioses |
| 02/28/2002 | DE10040016A1 Neue beta-Amyloid Inhibitoren, Verfahren zu deren Herstellung und deren Verwendung als Arzneimittel New beta-amyloid inhibitors, processes for their preparation and their use as medicaments |
| 02/28/2002 | DE10038709A1 Substituierte und unsubstituierte Benzooxathiazole sowie daraus abgeleitete Verbindungen Substituted and unsubstituted Benzooxathiazole and compounds derived therefrom |
| 02/28/2002 | DE10030318C1 Arzneimittelverpackung für die Eradikationstherapie Drug packaging for the eradication |
| 02/28/2002 | CA2740815A1 New uses for amino acid anticonvulsants |
| 02/28/2002 | CA2678754A1 Process for the preparation and purification of thiol-containing maytansinoids |
| 02/28/2002 | CA2541871A1 Selective androgen receptor modulators and methods of use thereof |
| 02/28/2002 | CA2456008A1 Stem cell differentiation |
| 02/28/2002 | CA2452346A1 Method for the identification of agents that inhibit or promote cataracts and uses thereof |
| 02/28/2002 | CA2425206A1 Treatment of trauma, and other indications |
| 02/28/2002 | CA2420289A1 10-aryl-11-hbenzo [b]fluorene derivatives and analogs for medicinal use |
| 02/28/2002 | CA2420274A1 Use of vitamin d derivatives as bone resorption inhibitors |
| 02/28/2002 | CA2420235A1 2-3-disubstituted quinuclidines as modulators of monoamine transporters and therapeutic and diagnostic methods based thereon |
| 02/28/2002 | CA2420194A1 Use of a porous carrier |
| 02/28/2002 | CA2420193A1 Compositions and methods for the diagnosis and treatment of tumor |
| 02/28/2002 | CA2420190A1 Oral fast-melt dosage form of a cyclooxygenase-2 inhibitor |
| 02/28/2002 | CA2420179A1 Composition and method for inhibiting platelet aggregation |
| 02/28/2002 | CA2420154A1 Dental composition for hypersensitive teeth |
| 02/28/2002 | CA2420024A1 Fused pyrazole derivatives being protein kinase inhibitors |
| 02/28/2002 | CA2419915A1 New sequences |